HARD DECISIONS IN INTENSIVE CARE UNIT

Intensivecareunitkapak

RENOVASCULAR DISEASES

Havva Nur Karaaslan

Ankara Bilkent City Hospital, Departmant of Intensive Care, Ankara, Türkiye

Karaaslan HN. Renovascular Disease. In: Turan S, editor. Hard Decisions in Intensive Care Unit. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.95-100.

ABSTRACT

Renovascular diseases occur as a result of an occlusion in the renal artery and its branches or other conditions that reduce its flow. Although the cause is usually atherosclerosis in advanced age, it is fibromuscular dysplasia in younger age. Hypertension occurs because of the activation of the renin angiotensin aldosterone system after general stenosis in the renal arteries. Hypertension at a young age or acute onset at an advanced age, resistant to medical treatment, should suggest renal artery stenosis. Renal Artery Doppler Ultrasound, Renal CT Angiography, and MR Angiography can reveal the pathology. In treatment, as well as multifaceted medical treatment for hypertension regulation, the aim is to open the stenosis with balloon angioplasty/stent placement. Surgical treatment has begun to be avoided with the improvement of endovascular approaches.

Keywords: Renovascular diseases; Renovascular hypertansion; Renal artery stenosis; Renal blood flow; Reninangiotensinaldosteron system activity; Renal artery baloon angioplasty

Referanslar

  1. Boutari C, Georgianou E, Sachinidis A, Katsimardou A, Christou K, Piperidou A, et al. Renovascular Hypertension: Novel Insights. Current hypertension reviews. 2020;16(1):24-9. Epub 2019/05/01. PubMed PMID: 31038069. [Crossref]  [PubMed]
  2. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Journal of the American College of Cardiology. 2006;47(6):1239-312. Epub 2006/03/21. PubMed PMID: 16545667. [Crossref]  [PubMed]
  3. Herrmann SM, Textor SC. Renovascular Hypertension. Endocrinology and metabolism clinics of North America. 2019;48(4):765-78. Epub 2019/10/28. PubMed PMID: 31655775; PubMed Central: PMC7184322. [Crossref]  [PubMed]  [PMC]
  4. Safian RD. Renal artery stenosis. Progress in cardiovascular diseases. 2021;65:60-70. Epub 2021/03/23. PubMed PMID: 33745915. [Crossref]  [PubMed]
  5. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. American journal of physiology Regulatory, integrative and comparative physiology. 2003;284(4):R893-912. Epub 2003/03/11. PubMed PMID: 12626356. [Crossref]  [PubMed]
  6. Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. The Urologic clinics of North America. 2001;28(4):793-803, ix. Epub 2002/01/17. PubMed PMID: 11791495. [Crossref]  [PubMed]
  7. Munoz-Moreno JM, Gamarra-Valverde NN, Muedas-Porras G, Nombera-Aznarán M, Aguilar-Figueroa F, Gulati M. Diagnostic and Therapeutic Approach to the Major Secondary Causes of Arterial Hypertension in Young Adults: A Narrative Review. Cardiology in review. 2024. Epub 2024/12/27. PubMed PMID: 39729595. [Crossref]  [PubMed]
  8. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. Journal of hypertension. 2009;27(7):1333-40. Epub 2009/04/15. PubMed PMID: 19365285. [Crossref]  [PubMed]
  9. Rana MN, Al-Kindi SG. Prevalence and manifestations of diagnosed fibromuscular dysplasia by sex and race: Analysis of >4500 FMD cases in the United States. Heart & lung : the journal of critical care. 2021;50(1):168-73. Epub 2020/10/19. PubMed PMID: 33069453. [Crossref]  [PubMed]
  10. Sanidas EA, Seferou M, Papadopoulos DP, Makris A, Viniou NA, Chantziara V, et al. Renal Fibromuscular Dysplasia: A Not So Common Entity of Secondary Hypertension. Journal of clinical hypertension (Greenwich, Conn). 2016;18(3):240-6. Epub 2016/03/13. PubMed PMID: 26970300; PubMed Central: PMC8031778. [Crossref]  [PubMed]  [PMC]
  11. Prasert N, Manosroi W, Hankamolsiri B, Wae-Uma M, Choonklai P. Factors predicting secondary hypertension in young adults with hypertension: a retrospective study. BMC cardiovascular disorders. 2025;25(1):57. Epub 2025/01/28. PubMed PMID: 39871170; PubMed Central: PMC11771069. [Crossref]  [PubMed]  [PMC]
  12. Tafur JD, White CJ. Renal Artery Stenosis: When to Revascularize in 2017. Current problems in cardiology. 2017;42(4):110-35. Epub 2017/03/23. PubMed PMID: 28325353. [Crossref]  [PubMed]
  13. Gunabushanam G, Chaubal R, Scoutt LM. Doppler Ultrasound of the Renal Vasculature. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 2024;43(8):1543-62. Epub 2024/04/24. PubMed PMID: 38654477. [Crossref]  [PubMed]
  14. Kawashima A, Sandler CM, Ernst RD, Tamm EP, Goldman SM, Fishman EK. CT evaluation of renovascular disease. Radiographics : a review publication of the Radiological Society of North America, Inc. 2000;20(5):1321-40. Epub 2000/09/19. PubMed PMID: 10992021. [Crossref]  [PubMed]
  15. Lao D, Parasher PS, Cho KC, Yeghiazarians Y. Atherosclerotic renal artery stenosis--diagnosis and treatment. Mayo Clinic proceedings. 2011;86(7):649-57. Epub 2011/07/02. PubMed PMID: 21719621; PubMed Central: PMC3127560. [Crossref]  [PubMed]  [PMC]
  16. Turgutalp K, Kiykim A, Özhan O, Helvaci I, Ozcan T, Yildiz A. Comparison of diagnostic accuracy of Doppler USG and contrast-enhanced magnetic resonance angiography and selective renal arteriography in patients with atherosclerotic renal artery stenosis. Medical science monitor : international medical journal of experimental and clinical research. 2013;19:475-82. Epub 2013/06/20. PubMed PMID: 23778330; PubMed Central: PMC3692376. [Crossref]  [PubMed]  [PMC]
  17. Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clinical radiology. 2002;57(7):617-24. Epub 2002/07/05. PubMed PMID: 12096862. [Crossref]  [PubMed]
  18. Dellegrottaglie S, Sanz J, Rajagopalan S. Technology insight: Clinical role of magnetic resonance angiography in the diagnosis and management of renal artery stenosis. Nature clinical practice Cardiovascular medicine. 2006;3(6):329-38. Epub 2006/05/27. PubMed PMID: 16729011. [Crossref]  [PubMed]
  19. Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2012;27(4):1403-9. Epub 2011/10/14. PubMed PMID: 21993376. [Crossref]  [PubMed]
  20. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet (London, England). 1999;353(9149):282-6. Epub 1999/02/03. PubMed PMID: 9929021. [Crossref]  [PubMed]
  21. Textor SC, Misra S, Oderich GS. Percutaneous revascularization for ischemic nephropathy: the past, present, and future. Kidney international. 2013;83(1):28-40. Epub 2012/11/16. PubMed PMID: 23151953; PubMed Central: PMC3532568. [Crossref]  [PubMed]  [PMC]
  22. Li Y, Cui WH, Wang J, Chen X, Zhang C, Zhu LZ, et al. Percutaneous revascularization for atherosclerotic renal artery stenosis: a meta-analysis. European review for medical and pharmacological sciences. 2022;26(19):7007-14. Epub 2022/10/21. PubMed PMID: 36263548. [Crossref]
  23. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. The New England journal of medicine. 2014;370(1):13-22. Epub 2013/11/20. PubMed PMID: 24245566; PubMed Central: PMC4815927. [Crossref]  [PubMed]  [PMC]
  24. Zeller T, Rastan A, Schwarzwälder U, Mueller C, Schwarz T, Frank U, et al. Treatment of instent restenosis following stent-supported renal artery angioplasty. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2007;70(3):454-9. Epub 2007/08/28. PubMed PMID: 17721946. [Crossref]  [PubMed]
  25. Tegtmeyer CJ, Selby JB, Hartwell GD, Ayers C, Tegtmeyer V. Results and complications of angioplasty in fibromuscular disease. Circulation. 1991;83(2 Suppl):I155-61. Epub 1991/02/01. PubMed PMID: 1825043. [PubMed]
  26. Surowiec SM, Sivamurthy N, Rhodes JM, Lee DE, Waldman DL, Green RM, et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Annals of vascular surgery. 2003;17(6):650-5. Epub 2003/10/10. PubMed PMID: 14534846. [Crossref]  [PubMed]
  27. Ricco JB, Belmonte R, Illuminati G, Barral X, Schneider F, Chavent B. How to manage hypertension with atherosclerotic renal artery stenosis? The Journal of cardiovascular surgery. 2017;58(2):329-38. Epub 2016/12/22. PubMed PMID: 27998047. [Crossref]  [PubMed]